News | Breast Imaging | June 12, 2017

Insignia Medical Systems, the pioneering, UK based, Enterprise Imaging provider, confirms a new contract with Avon Breast Screening (ABS)

ABS Clinical Director Alexandra Valencia, M.D.,  and consultant radiographer Gillian Clark using Insignia.

ABS Clinical Director Alexandra Valencia, M.D.,  and consultant radiographer Gillian Clark using Insignia.


ABS, one of the largest breast departments in the country, first signed with Insignia in 2010, and have confirmed a further 5 year managed service contract with PACS provider Insignia.

The Avon Breast Screening programme invites more than 140,000 women from the area for breast screening. A service which is coordinated through Avon Breast Screening, based in the Bristol Breast Care Centre at Southmead Hospital.

Supplying their InSight Mammo PACS solution, one of the leading Breast Care PACS in the UK with workflows specifically developed for screening, symptomatic and assessment, to the center.

Clare McLachlan, Acting Superintendent, Avon Breast Screening commented “We selected Insignia because they provide excellent support with regular updates. They are constantly improving their software to reflect new technologies such as tomosynthesis, and their software is easy to use facilitating film reading of mammograms.”

Certified to NBSS Level 2, InSight Mammo improves workflow for Consultants and helps speed up diagnosis. Support for multiple modalities including FFDM, MRI, Gamma Imaging and ultrasound enables the entire imaging record to be included in the advanced hanging protocols.

Tomosynthesis imaging is supported within InSight Mammo delivering the latest technology for the Radiologists and Clinicians.

With the continued contract in place, Insignia and ABS are in discussion with other local Trusts in regards to image sharing to provide joined up Breast Care across the region. 

For more information: http://www.insigniamedical.co.uk/


Related Content

News | Enterprise Imaging

Feb. 12, 2026 — Agfa HealthCare continued its strong business momentum across the U.S. market, as health systems expand ...

Time February 20, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
Subscribe Now